Citius Oncology, Stock Price History
CTOR Stock | 0.94 0.06 6.00% |
If you're considering investing in Citius Stock, it is important to understand the factors that can impact its price. As of today, the current price of Citius Oncology, stands at 0.94, as last reported on the 28th of November, with the highest price reaching 1.07 and the lowest price hitting 0.92 during the day. Citius Oncology, secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12% return per unit of risk over the last 3 months. Citius Oncology, exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Citius Oncology,'s Standard Deviation of 6.71, risk adjusted performance of (0.09), and Mean Deviation of 4.98 to double-check the risk estimate we provide.
At this time, Citius Oncology,'s Total Stockholder Equity is relatively stable compared to the past year. As of 11/28/2024, Stock Based Compensation is likely to grow to about 2.4 M, while Common Stock Shares Outstanding is likely to drop slightly above 57 M. . Citius Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Citius |
Sharpe Ratio = -0.1214
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | CTOR |
Estimated Market Risk
6.54 actual daily | 58 58% of assets are less volatile |
Expected Return
-0.79 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Citius Oncology, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Citius Oncology, by adding Citius Oncology, to a well-diversified portfolio.
Price Book 4.5515 | Enterprise Value 116.2 M | Shares Outstanding 2 M | Shares Short Prior Month 10.6 K | Market Capitalization 116.2 M |
Citius Oncology, Stock Price History Chart
There are several ways to analyze Citius Stock price data. The simplest method is using a basic Citius candlestick price chart, which shows Citius Oncology, price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 5, 2024 | 1.88 |
Lowest Price | November 22, 2024 | 0.85 |
Citius Oncology, November 28, 2024 Stock Price Synopsis
Various analyses of Citius Oncology,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Citius Stock. It can be used to describe the percentage change in the price of Citius Oncology, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Citius Stock.Citius Oncology, Price Daily Balance Of Power | (0.40) | |
Citius Oncology, Price Action Indicator | (0.09) | |
Citius Oncology, Accumulation Distribution | 9,847 | |
Citius Oncology, Price Rate Of Daily Change | 0.94 |
Citius Oncology, November 28, 2024 Stock Price Analysis
Citius Stock Price History Data
The price series of Citius Oncology, for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 1.19 with a coefficient of variation of 22.69. The prices are distributed with arithmetic mean of 1.33. The median price for the last 90 days is 1.24.Open | High | Low | Close | Volume | ||
11/27/2024 | 1.00 | 1.07 | 0.92 | 0.94 | 70,245 | |
11/26/2024 | 0.89 | 1.00 | 0.85 | 1.00 | 106,200 | |
11/25/2024 | 0.91 | 0.91 | 0.85 | 0.85 | 92,403 | |
11/22/2024 | 0.99 | 1.01 | 0.85 | 0.85 | 89,400 | |
11/21/2024 | 1.03 | 1.03 | 0.96 | 0.98 | 34,900 | |
11/20/2024 | 1.00 | 1.02 | 0.95 | 0.99 | 49,750 | |
11/19/2024 | 0.97 | 1.05 | 0.97 | 0.98 | 27,600 | |
11/18/2024 | 1.04 | 1.07 | 0.97 | 0.97 | 41,439 | |
11/15/2024 | 1.05 | 1.13 | 1.03 | 1.06 | 51,703 | |
11/14/2024 | 1.18 | 1.19 | 1.06 | 1.07 | 85,500 | |
11/13/2024 | 1.35 | 1.35 | 1.18 | 1.22 | 74,499 | |
11/12/2024 | 1.40 | 1.41 | 1.25 | 1.31 | 114,274 | |
11/11/2024 | 1.29 | 1.43 | 1.18 | 1.35 | 459,704 | |
11/08/2024 | 1.30 | 1.39 | 1.21 | 1.27 | 89,040 | |
11/07/2024 | 1.22 | 1.31 | 1.18 | 1.26 | 47,707 | |
11/06/2024 | 1.13 | 1.32 | 1.13 | 1.18 | 115,147 | |
11/05/2024 | 1.02 | 1.20 | 1.02 | 1.19 | 167,300 | |
11/04/2024 | 1.10 | 1.12 | 1.01 | 1.03 | 70,020 | |
11/01/2024 | 1.16 | 1.21 | 1.14 | 1.14 | 33,354 | |
10/31/2024 | 1.22 | 1.25 | 1.15 | 1.19 | 17,600 | |
10/30/2024 | 1.18 | 1.27 | 1.15 | 1.21 | 21,700 | |
10/29/2024 | 1.20 | 1.27 | 1.19 | 1.21 | 45,800 | |
10/28/2024 | 1.21 | 1.21 | 1.13 | 1.17 | 62,194 | |
10/25/2024 | 1.23 | 1.25 | 1.17 | 1.19 | 24,500 | |
10/24/2024 | 1.22 | 1.27 | 1.14 | 1.21 | 51,100 | |
10/23/2024 | 1.31 | 1.39 | 1.20 | 1.24 | 108,400 | |
10/22/2024 | 1.23 | 1.40 | 1.21 | 1.31 | 152,951 | |
10/21/2024 | 1.29 | 1.32 | 1.13 | 1.19 | 131,446 | |
10/18/2024 | 1.09 | 1.36 | 1.09 | 1.24 | 214,239 | |
10/17/2024 | 1.06 | 1.17 | 1.03 | 1.08 | 60,300 | |
10/16/2024 | 1.03 | 1.25 | 1.01 | 1.08 | 183,859 | |
10/15/2024 | 1.03 | 1.05 | 0.94 | 1.00 | 82,818 | |
10/14/2024 | 1.08 | 1.08 | 1.01 | 1.05 | 93,359 | |
10/11/2024 | 0.93 | 1.01 | 0.93 | 1.01 | 36,662 | |
10/10/2024 | 0.94 | 1.00 | 0.94 | 0.97 | 38,068 | |
10/09/2024 | 1.02 | 1.07 | 0.93 | 0.95 | 110,900 | |
10/08/2024 | 1.05 | 1.08 | 1.03 | 1.03 | 23,100 | |
10/07/2024 | 1.17 | 1.18 | 1.05 | 1.08 | 53,377 | |
10/04/2024 | 1.18 | 1.25 | 1.11 | 1.19 | 87,284 | |
10/03/2024 | 1.34 | 1.40 | 1.13 | 1.18 | 127,489 | |
10/02/2024 | 1.35 | 1.38 | 1.30 | 1.30 | 22,423 | |
10/01/2024 | 1.39 | 1.39 | 1.30 | 1.35 | 63,258 | |
09/30/2024 | 1.41 | 1.43 | 1.33 | 1.39 | 45,407 | |
09/27/2024 | 1.40 | 1.50 | 1.30 | 1.40 | 163,311 | |
09/26/2024 | 1.53 | 1.54 | 1.30 | 1.43 | 161,970 | |
09/25/2024 | 1.60 | 1.63 | 1.46 | 1.52 | 214,596 | |
09/24/2024 | 1.78 | 1.80 | 1.47 | 1.68 | 234,820 | |
09/23/2024 | 1.86 | 1.91 | 1.61 | 1.82 | 1,922,445 | |
09/20/2024 | 1.51 | 1.65 | 1.51 | 1.60 | 672,052 | |
09/19/2024 | 1.64 | 1.73 | 1.56 | 1.67 | 155,818 | |
09/18/2024 | 1.56 | 1.66 | 1.55 | 1.55 | 69,108 | |
09/17/2024 | 1.64 | 1.67 | 1.53 | 1.63 | 35,700 | |
09/16/2024 | 1.69 | 1.72 | 1.62 | 1.63 | 67,200 | |
09/13/2024 | 1.66 | 1.79 | 1.63 | 1.63 | 71,319 | |
09/12/2024 | 1.64 | 1.70 | 1.61 | 1.64 | 87,582 | |
09/11/2024 | 1.75 | 1.75 | 1.66 | 1.69 | 48,646 | |
09/10/2024 | 1.79 | 1.79 | 1.71 | 1.78 | 18,441 | |
09/09/2024 | 1.74 | 1.74 | 1.59 | 1.74 | 29,770 | |
09/06/2024 | 1.81 | 1.86 | 1.65 | 1.77 | 68,436 | |
09/05/2024 | 1.74 | 1.93 | 1.70 | 1.88 | 110,800 | |
09/04/2024 | 1.67 | 1.80 | 1.67 | 1.73 | 55,623 |
About Citius Oncology, Stock history
Citius Oncology, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Citius is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Citius Oncology, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Citius Oncology, stock prices may prove useful in developing a viable investing in Citius Oncology,
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 64.1 M | 57 M |
Citius Oncology, Stock Technical Analysis
Citius Oncology, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
All Next | Launch Module |
Citius Oncology, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Citius Oncology,'s price direction in advance. Along with the technical and fundamental analysis of Citius Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Citius to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.09) | |||
Jensen Alpha | (1.13) | |||
Total Risk Alpha | (1.92) | |||
Treynor Ratio | (0.40) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Citius Stock Analysis
When running Citius Oncology,'s price analysis, check to measure Citius Oncology,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Citius Oncology, is operating at the current time. Most of Citius Oncology,'s value examination focuses on studying past and present price action to predict the probability of Citius Oncology,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Citius Oncology,'s price. Additionally, you may evaluate how the addition of Citius Oncology, to your portfolios can decrease your overall portfolio volatility.